A Multiple Dose of HL237 in Healthy Male Subject

Clinical trial NCT03896594 · UNKNOWN

Trial details

NCT number: NCT03896594
Sponsor: Hanlim Pharm. Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2018-12-24
Primary completion: 2019-06-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.